Grant: Engage Grants Program
Dalhousie University
$24,607.00
Zebrafish model for behavioural screening of neuroactive substances
FY 2014-15
Summary
Research proposed here aims to develop a zebrafish model for examining behavioural indicators of neuralfunction that can be incorporated into screens for gene actions, environmental toxins, and drugs. The partnercompany is DMF Medical Inc, a Nova Scotia based corporation dedicated to research leading to improvedoutcomes following anesthesia and the company is interested in this project as a means of understanding themechanisms underlying detrimental post-operative side effects of commonly used anaesthetics. The firstproject will involve the use of measurements of behavioural parameters (movements, posture, responsiveness)to characterize the acute effects of sevoflurane, desflurane and isoflurane and determine dose-response curvesand recovery periods in zebrafish. The second project will involve the development of learning paradigmssuitable for testing long-term effects of anaesthetics on cognitive functions. Our lab already established anolfactory conditioning paradigm for zebrafish and we will compare this paradigm to ones involving vision andhearing to provide a robust and efficient screening procedure which is optimized for zebrafish. The thirdproject will then involve the examination of anaesthetic-induced cognitive deficits. Specifically, we willconduct pilot studies to examine the long-term effects of anaesthetics on the abilities of fish to form and retainmemories associated with the learning paradigms. By providing novel screening procedures for neurotoxiceffects of anaesthetics and/or their metabolites, the project will facilitate the company's goal of improvinganesthesia technology, but the work will also offer a basis for the development of screening procedures forbroader classes of drugs and/or genetic manipulations which affect behaviour and learning and thereby shedlight on underlying neural mechanisms. Future screens for environmental toxins based on these procedures willalso provide a better understanding of the effects of anthropogenic chemicals being introduced into aquaticecosystems. Finally, by funding several students and recent graduates the project will also benefit our nextgeneration of research scientists by engaging them in meaningful research.
Program
Engage Grants Program
Recipient
Location
Nova Scotia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
462743-2014
Name nom
Croll, Roger
Department département
Physiology and Biophysics
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
24607
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Partie
1
Nb partie
1
Application title
Zebrafish model for behavioural screening of neuroactive substances
Keyword
NSERC
Application summary
Research proposed here aims to develop a zebrafish model for examining behavioural indicators of neuralfunction that can be incorporated into screens for gene actions, environmental toxins, and drugs. The partnercompany is DMF Medical Inc, a Nova Scotia based corporation dedicated to research leading to improvedoutcomes following anesthesia and the company is interested in this project as a means of understanding themechanisms underlying detrimental post-operative side effects of commonly used anaesthetics. The firstproject will involve the use of measurements of behavioural parameters (movements, posture, responsiveness)to characterize the acute effects of sevoflurane, desflurane and isoflurane and determine dose-response curvesand recovery periods in zebrafish. The second project will involve the development of learning paradigmssuitable for testing long-term effects of anaesthetics on cognitive functions. Our lab already established anolfactory conditioning paradigm for zebrafish and we will compare this paradigm to ones involving vision andhearing to provide a robust and efficient screening procedure which is optimized for zebrafish. The thirdproject will then involve the examination of anaesthetic-induced cognitive deficits. Specifically, we willconduct pilot studies to examine the long-term effects of anaesthetics on the abilities of fish to form and retainmemories associated with the learning paradigms. By providing novel screening procedures for neurotoxiceffects of anaesthetics and/or their metabolites, the project will facilitate the company's goal of improvinganesthesia technology, but the work will also offer a basis for the development of screening procedures forbroader classes of drugs and/or genetic manipulations which affect behaviour and learning and thereby shedlight on underlying neural mechanisms. Future screens for environmental toxins based on these procedures willalso provide a better understanding of the effects of anthropogenic chemicals being introduced into aquaticecosystems. Finally, by funding several students and recent graduates the project will also benefit our nextgeneration of research scientists by engaging them in meaningful research.